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SUMMARY – Recently migraine has been associated with increased arterial stiffness, procoa-
gulant state, increased incidence of cerebral white matter lesions (WML) and stroke. Our aim was 
to compare the characteristics of migraineurs to headache free controls regarding their functional 
carotid ultrasound parameters. Sixty patients (45 women) with migraine (mean age 40.42±10.61 ye-
ars) were compared with 45 controls (30 women) with no prior history of repeating headache (mean 
age 38.94±5.46 years) using E-tracking software on Alpha 10 ultrasound platform. Student’s t-test 
was used on statistical analysis with alpha <0.05. All tested carotid vascular parameters were worse 
in patients with migraine including increased intima-media thickness, greater carotid diameter and 
carotid diameter change, as well as several arterial stiffness indices. Additionally, patients with mi-
graine had greater incidence of homozygous mutations for procoagulant genes (MTHFR (C677T), 
PAI-1 and ACE I/D) than expected. Computed tomography and magnetic resonance imaging of the 
brain showed WML in 11 patients, four of them migraine with aura patients. Since we established 
increased carotid stiffness and higher frequency of procoagulant gene mutations in migraineurs, we 
propose prospective ultrasound monitoring in such patients, especially those with detected WML, 
in order to timely commence more active and specific preventive stroke management strategies.
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Introduction
Migraine is a common disabling primary head-
ache and a neurovascular disorder. Several epidemio-
logic studies addressed migraine as an independent 
risk factor for ischemic cerebrovascular disease1,2. A 
meta-analysis by Schurks et al. states that migraine 
was associated with a twofold higher risk of ischemic 
stroke apparent only among people who had migraine 
with aura (MA), those aged less than 45, smokers, 
women in general, and women using oral contracep-
tives1. Interestingly, there was no association between 
migraine and myocardial infarction or death due to 
Correspondence to: Miljenka-Jelena Jurašić, MD, PhD, University 
Department of Neurology, Sestre milosrdnice University Hospi-
tal Center, Vinogradska c. 29, HR-10000 Zagreb, Croatia 
E-mail: mjjurasic@gmail.com
Received October 2, 2014, accepted November 16, 2015
cardiovascular disease1. In addition, results of a large 
prospective cohort suggest that women with MA are 
at an increased risk of experiencing transient ischemic 
attack (TIA) or ischemic stroke, but with good func-
tional outcome2. A recently published review con-
firmed the association between migraine, particularly 
MA, and ischemic stroke, while implicating several 
pathophysiological mechanisms of the ischemic event 
genesis3. It has also been confirmed that genetic poly-
morphisms of the following factors: factor V Leiden, 
factor V (H1299R), prothrombin G20210A, fac-
tor XIII (V34L), β-fibrinogen, MTHFR (C677T), 
MTHFR (A1298C), APO E, PAI-1, HPA-1 and 
ACE I/D, are most likely implicated in the founda-
tion of stroke related to migraine3.
Cerebrovascular disease in very early stages mani-
fests as endothelial dysfunction, increase of arterial 
stiffness and increase in the intima-media thickness 
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(IMT)4. Vascular endothelium is involved in four op-
posite regulatory mechanisms: vasodilatation-vaso-
constriction, growth inhibition-growth promotion, 
antiaggregation-proaggregation, and anti-inflamma-
tory-proinflammatory action. Alterations in these 
mechanisms may serve as a common mechanistic 
pathway to both migraine and cerebrovascular dis-
ease4.  Results of the MIRACLES study, published in 
2011, showed substantial prevalence of hypertension-
migraine comorbidity with a higher probability of 
cerebrovascular events, compared to simply hyperten-
sive patients5. In a study by Nagai et al., migraine in 
the elderly was identified as a possible clinical mani-
festation of enhanced arterial stiffness6. So far, chang-
es in arterial stiffness have been most often associ-
ated with systolic hypertension or pulse wave velocity 
(PWV) increase. Namely, PWV is generally regarded 
as one of the closest representations of changes in ar-
terial mechanics caused by provocative factors, and is 
the gold standard of arterial stiffness measurement. 
Increase in PWV was also labeled as an independent 
predictor of cerebrovascular disease occurrence7. 
E-tracking® is semi-automated software for arte-
rial wall biomechanical evaluation8. The purpose of 
this study was to explore viscoelastic common carotid 
artery characteristics in patients with migraine using 
several E-tracking® computed parameters and com-
pare them with headache free controls in search for 
the possible evidence for early functional disbalance 
and subclinical atherosclerotic damage. 
Patients and Methods
The investigation was performed on 60 migraine 
patients (45 women) and 45 controls (30 women) with 
no prior history of repeating headache. Study patients 
were randomly selected from a pool of our episodic 
migraine patients evaluated in the last quarter of 
2009. Controls were randomly selected from clini-
cally healthy individuals within the same age range 
(18-55 years) examined in our cerebrovascular labora-
tory during the same period. Participants signed the 
informed consent previously approved by the Hospi-
tal Ethics Committee and underwent standard neu-
rological examination. Migraine questionnaire was 
filled in by migraine patients providing the following 
information: age, sex, age at migraine onset, number 
of migraine days per month, headache duration per 
episode, maximum pain severity using visual analog 
scale (VAS), coexistence of other headaches, migraine 
triggers, presence of aura, and migraine therapy ad-
ministered. Additional information noted in all study 
subjects included years of education, marital status, 
smoking (with pack-year assessment for active smok-
ers), alcohol consumption, hypertension (if present), 
diabetes mellitus (if present), heart disease (if pres-
ent), use of contraceptives, body height, and body 
weight. The following parameters were calculated: 
life-time migraine duration (yrs), pulse pressure (PP, 
difference between systolic and diastolic blood pres-
sure values), body mass index (BMI), and pack-year 
number for the group of active smokers (one pack of 
cigarettes smoked per day for one year). Laboratory 
blood analysis was performed as screening only for 
migraine patients with the following parameters: he-
moglobin, erythrocyte sedimentation rate (ESR), C-
reactive protein (CRP), red blood cell count, leukocyte 
count, total cholesterol, LDL, HDL, triglycerides, 
and haplotype analysis for factor V Leiden, factor II 
(prothrombin G20210A), MTHFR (C677T), PAI-1, 
ACE I/D and APO E. Migraine patients were also 
asked to undergo magnetic resonance imaging (MRI) 
to establish the potential presence of cerebral white 
matter lesions (WML). 
Color coded flow imaging carotid Doppler (CDFI) 
and E-tracking were performed on Alpha-10 (Aloka 
Co., Ltd., Tokyo, Japan) with 13 MHz linear trans-
ducer in B and M modes using standard protocols 
and E-tracking® system. Noninvasive brachial blood 
pressure (BP) was measured thrice on the right arm 
in supine position after five minute bed rest with an 
Omron digital automatic oscillometric BP monitor. 
The mean BP was used for E-tracking®. Data collec-
tion was performed by a single investigator who was 
not informed on the patient’s involvement in this study 
and with respect to the Recommendations of the Task 
Force for arterial stiffness during headache free in-
tervals9. All measurements were performed on distal 
common carotid artery (CCA; 1.5 cm proximally to 
carotid bifurcation) in supine position with head el-
evation of up to 30° and side tilt of 30° to the left and 
then to the right. The following ultrasound parameters 
were evaluated: carotid IMT, systolic and diastolic ca-
rotid inter-adventitial diameters (CID) and difference 
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between the two (CIDc), carotid beta stiffness (BSI) 
index, elasticity coefficient (Ep), arterial compliance 
(AC), augmentation index (AI) and one-point beta 
pulse wave velocity (bPWV) bilaterally9.
Descriptive statistics and frequency tables were 
created. Quantitative data were analyzed by Kolm-
ogorov-Smirnov test to verify the normality of dis-
tribution and Bartlett-Box test was used to check 
homoscedasticity of variance. SPSS (version 8.0 for 
Windows) was used to compare the means of con-
tinuous variables with Student’s t-test for independent 
samples or, if appropriate, Mann-Whitney U-test (for 
2 groups) was substituted, both at a threshold value of 
0.05 (two-tailed p value).
Results
In our group of migraineurs (n=60) there were 45 
women (mean age 40.42±10.61 years), while in the 
control group (n=45) there were 30 women (mean age 
38.94±5.46 years). Descriptive statistics is shown in 
Table 1. The mean life-time headache duration was 
16.24±12.20 years (CI 2.86): in 46 patients beginning 
in adolescence and adulthood, in two patients begin-
ning in puberty and in seven patients with later onset 
(after 40 years); five patients could not recollect the 
age of migraine onset. MA was reported by 19 pa-
tients (32%). The mean number of headache days per 
month was 9.82±9.37 (CI 2.20), range 1-30, and the 
mean pain severity on VAS was 7.52±1.15 (CI 0.27). 
Twenty-eight patients reported to have an additional 
headache (most often tension type headache). The aver-
age headache period duration in patient group ranged 
from 30 minutes to 7 days. Most of the patients re-
sorted to therapy with nonsteroidal antiinflammatory 
drugs (NSAIDs) (n=43), two received intravenous (iv) 
therapy, one was taking ergotamine, one was with-
out medication aid, and only 13 were taking triptans. 
Thirteen patients reported no migraine triggers; of the 
remaining, 28 patients pointed to multiple triggers 
and 19 opted for only one trigger. Single triggers were 
categorized as follows: physical conditions (n=19), 
weather change (n=15), stress (n=14), premenstrual 
syndrome (PMS, n=13), emotions (n=5), ovulation 
(n=5), food and drink (n=5) and menstruation (n=4). 
We would like to emphasize that the most prevalent 
migraine triggers (n=22) were those associated with 
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Additionally, 24 patients had 14 years, 28 had 12 
years, 4 had 16 years and the remaining four patients 
had 8 years of schooling. There were 44 married, 13 
single and 3 divorced patients. Twenty-seven patients 
claimed they did not take alcoholic drinks and 33 
reported having occasional drink. There were 3 hy-
pertensive patients, all medicated and well controlled 
(repeated BP measurements revealed normal values); 
two patients were diabetic (one treated with diet and 
one with oral medication; blood glucose measurement 
showed normal values in both cases). None of the pa-
tients had cardiac disease. There were 22 (37%) active 
smokers among migraineurs with the mean pack-year 
number 11.4±13.31. Four women were taking oral 
contraceptives. 
Blood sample measurements of inflammation pa-
rameters like ESR, leukocyte count and CRP were all 
within the normal laboratory values, as were red blood 
cell count and hemoglobin values. Total cholesterol 
was 5.63±1.21 mmol/L (CI 0.32), LDL 3.50±1.10 
mmol/L (CI 0.30), while HDL and triglycerides were 
1.50±0.50 mmol/L (CI 0.10) and 1.38±0.99 mmol/L 
(CI 0.26), respectively. The mean waist circumference 
was 85.63±13.66 cm (CI 3.61).
The mean BP was 123.07±12.81 mm Hg over 
79.17±10.07 mm Hg in migraineurs versus 116.78±7.99 
mm Hg over 74.56±6.73 mm Hg in controls (p<0.05). 
There was no statistically significant PP difference be-
tween patients and controls (43.91±9.33 mm Hg ver-
sus 42.22±5.39 mm Hg). Heart rate was normal in all 
patients (69.89±8.64 beats/min, CI 2.28). 
Color coded carotid Doppler showed plaques in 
four patients, mild stenosis in one patient and moder-
ate stenosis in one patient, while 54 patients showed 
no pathology. The mean IMT was normal in both 
groups, but slightly greater in migraine patients. The 
same was also found for CID and CIDc. AC in mi-
graineurs showed decreased carotid compliance, while 
all other markers implied increased arterial stiffness 
(Table 2), with no side-to-side differences (p>0.05). 
Genetic polymorphism analysis revealed homozy-
gotic mutations (HoM) for MTHFR (C677T) in 
three and heterozygous mutation (HeM) in 22 pa-
tients, HoM for PAI-1 in 11 and HeM in 22 patients, 
and HoM for ACE in nine and HeM in 18 patients. 
Single mutations occurred in 14 patients, coexisting 
mutations of two aforementioned genes occurred in 
12 patients, while another nine patients had three co-
existing mutations (11 patients were mutation free). 
There were no HoM discovered for factor V Leiden, 
factor II (prothrombin G20210A) and APO E. Only 
2 HeM were detected for factor V Leiden and APO E; 
all other patients were mutation free. Brain MRI was 
performed in 20 patients (others refused brain imag-
ing): periventricular WML were found in 11 patients, 
4 in MA patients, and two patients had evidence of 
previous small brain stem ischemic lesions.









R L R L R L R L
Migraineurs
Mean 103.64* 107.43* 0.88* 0.85* 9.99 11.11 6.13* 6.21*
SD 38.27 45.19 0.33 0.33 10.50 14.59 1.06 1.24
CI (95%) 8.96 10.59 0.08 0.08 2.46 3.42 0.25 0.29
Controls
Mean 70.95 68.80 1.10 1.10 NA NA 5.07 4.98
SD 26.27 26.80 0.40 0.44 NA NA 0.95 0.95
CI (95%) 7.28 7.43 0.11 0.12 NA NA 0.26 0.26
*p<0.01; NA = not available, there were no side-to-side differences detected; SD = standard deviation; CI = confidence interval; Ep = elasticity 
coefficient; AC = arterial compliance; AI = augmentation index; βPWV = one-point beta pulse wave velocity; CIDc = carotid inter-adventitial 
diameter change; R = right; L = left.
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Discussion
Migraine patients in this study had significantly 
higher values of IMT, BSI, Ep, AI and βPWV indi-
cating increased carotid stiffness. AC was decreased 
compared to controls, as is usually expected in early 
vascular changes. The average life-time migraine du-
ration in our patients was 16 years, but it was, so far, 
discovered that functional properties in peripheral ar-
teries are altered even in patients with migraine of a 
relatively recent onset (<6 years), even more so in mus-
cular arteries10. Our previous studies have shown that 
over time, due to age increase alone, changes of vas-
cular elasticity can be detected and predicted11. How-
ever, there were no significant differences in our study 
between the morphological and functional measure-
ments in either CCA or between sexes. A recent study 
showed results similar to ours, i.e. there was no dif-
ference between left and right CCA lumen diameter 
and IMT despite the fact that men had larger carotid 
diameters in general12. 
It is widely accepted that carotid PWV directly re-
flects arterial stiffness while central pressure or AI is 
its indirect or surrogate measure. Increase in PWV is 
attributed to endothelial cell regulation that contrib-
utes to structural changes of arterial tunica media that 
might occur independently, as well. Furthermore, in-
creased aortic PWV in young people was labeled as a 
possible mechanism underlying the increased CV risk 
in migraine patients13. Similar was recently also con-
firmed in chronic migraine patients, where both in-
creased arterial stiffness and endothelial dysfunction 
were discovered14. Liman et al. confirmed increase in 
arterial stiffness in migraine patients, even without 
impairment of peripheral endothelial function15. In a 
study by de Hoon et al., interictally increased arte-
rial stiffness was concluded to suggest that migraine 
might be part of a more generalized vascular disor-
der16. Recently, multiple linear regression analysis re-
vealed that migraine was an independent determinant 
of AI after adjustment for confounding factors such 
as age, sex, body height, systolic BP, hypertension 
medication, hyperlipidemia, diabetes mellitus and 
heart rate6. Our migraine patients had significantly 
higher IMT values compared to controls (still within 
the healthy boundaries) suggesting stratification, i.e. 
IMT quintiles predicting the risk of stroke17. Kovaite 
et al. found that SCORE risk assessment may be used 
to assess cardiovascular risk as low (<5%) or increased 
(≥5%) selecting cut-off value of 0.078 mm for IMT 
and 8.95 m/s for PWV18. Our previous study showed 
that, due to age increase alone, changes of vascular 
stiffness could be detected and predicted11. Still, it 
has been established that age and sex independent-
ly influence both parameters, while BMI and LDL 
cholesterol independently reflect only carotid IMT 
changes19. The aforementioned parameters are espe-
cially important since they mark two separate enti-
ties of vascular damage: functional – arterial stiffness 
(PWV) and morphological – subclinical atherosclero-
sis (carotid IMT). 
Only a few of our patients had conventional vas-
cular risk factors, probably because of their relatively 
young age. Still, our patients were more prone to 
smoking (one-third were active smokers) compared 
to controls. Agreeably, Lopez-Mesonero et al. found 
habitual smoking of 5 cigarettes daily to invoke mi-
graine attacks by one-third more often20. Smoking 
is proatherogenic through blood clot formation, en-
dothelial dysfunction and lipid peroxidation, all per-
sisting long after smoking cessation21. Previous stud-
ies have stated that diameter increase, IMT increase 
and plaque formation are early irreversible markers of 
atherosclerosis, as are systolic BP and PP increase22. 
Additionally, significantly higher BP values, but 
still within the healthy boundaries, were observed 
in our migraine patients and recently by Harandi et 
al. proposing the need for greater vigilance in pa-
tient screening and management23. Both systolic and 
diastolic BP were equally increased in our patients, 
so no difference in PP values was detected between 
the groups. 
Additionally, our migraine patients had a high in-
cidence of homozygous and heterozygous mutations 
for MTHFR, PAI-1 and ACE. Other tested genes 
(factor V Leiden, factor II (prothrombin G20210A), 
and APO E) did not differ between our groups, as was 
also noted by Pizza et al.3 So far, PAI-1 was found sig-
nificantly lower in migraineurs (along with tPA) sup-
porting involvement of hemostasis in the pathogen-
esis of migraine24. Proatherogenic homozygous ACE 
mutation is more frequent in migraine with aura and 
is deemed responsible for the occurrence of migraine 
attacks and their frequency. Additionally, it seems 
that this phenomenon is even stronger when associ-
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ated with MTHFR gene polymorphism, especially in 
Caucasians. Furthermore, MTHFR mutation causes 
mild elevation in homocysteine levels, which in turn 
causes vascular abnormalities and migraine, as well as 
trigemino-vascular activation3. Migraine susceptibil-
ity in MTHFR polymorphism could be explained by 
ischemia or hypoxia that evoke cerebrovascular inci-
dents, or by increased platelet stickiness. However, 
increased homocysteine suppresses Na+-K+-ATPase 
activity in parietal, prefrontal and cingulated cortex 
of rats, offering the possibility of involvement of both 
neurons and glia25. Lastly, platelet activation and plas-
ma coagulability are increased during migraine at-
tacks, implying that genes affecting vascular endothe-
lial function could play a significant role in cerebral 
blood flow changes detected in migraineurs3. 
Only two of our patients had evidence of previ-
ous small and asymptomatic cerebrovascular events in 
posterior circulation (brain stem ischemia) and there 
were periventricular WML in 11 patients (four of 
those in MA patients). Additionally, there was no evi-
dence of occipital brain lesions in our patients, labeled 
as specific to patients with migraine in the CAMERA 
study26. Still, longitudinal studies are needed to assess 
whether these lesions have a tendency to progress and 
would have relevant (long-term) functional or clinical 
correlates. So far, epidemiologic data showed the risk 
of cerebrovascular events in migraineurs to be most 
prominent in the 45-55 age group (approximately 
twofold) and even more so if the patients are female, 
smokers and taking oral contraceptives (seven-fold)27. 
Additionally, Lee et al. report that this increased risk 
may be explained by a reduced number of circulat-
ing endothelial progenitor cells, a surrogate biologic 
marker of vascular function28. In our patient group, 
there were no signs of chronic inflammation as proven 
by laboratory testing, i.e. leukocyte count and CRP 
levels. CRP can be used as a measure of endothelial 
health or dysfunction promoted by chronic inflamma-
tion, facilitation of lipoprotein-macrophage interac-
tion, all eventually inciting atherosclerosis29.  
Lastly, we would like to state pitfalls of our inves-
tigation: small sample size, lack of age, sex and risk 
factor matching, and lack of isolation of migraineurs 
with occipital WML or with homozygous mutation 
of procoagulant genes in comparison to matched con-
trols. 
Conclusion
In conclusion, based on the results of this study, 
we can say that our patients with episodic migraine 
were at a low risk of cerebrovascular disease, but had 
started to stratify from expected values of functional 
vascular parameters thus proving vascular remodel-
ing. Therefore, ultrasound and general health moni-
toring are advisable so that active preventive measures 
against potential cerebrovascular disease can be initi-
ated on time. Furthermore, prospective studies should 
be performed to evaluate the rate of progression of 
IMT, BSI, Ep, AI, βPWV and AC with respect to 
genetic polymorphism, thus determining their impor-
tance as markers of cerebrovascular and cardiovascu-
lar incidents. 
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Sažetak 
MIGRENA, KAROTIDNA KRUTOST I GENETSKI POLIMORFIZAM
V. Bašić Kes, M-J. Jurašić, I. Zavoreo, L. Ćorić i K. Rotim
Nedavno se pojam migrene povezao s povećanom arterijskom krutosti, prokoagulantnim stanjem, povećanim brojem 
zamijećenih otšećenja bijele moždane tvari te moždanim udarom. Naš cilj je bio usporediti funkcijske karakteristike mje-
renja u zajedničkoj karotidnoj arteriji kod bolesnika s migrenom i u kontrolnoj skupini osoba bez učestalih glavobolja. U 
ispitivanje je bilo uključeno šezdeset ispitanika (45 žena) s migrenom (srednje dobi 40,42±10,61 godina) te 45 ispitanika 
u kontrolnoj skupini (30 žena) koji u anamnezi nisu imali učestale glavobolje (srednje dobi 38,94±5,46 godina). Mjerenja 
su provedena putem korisničke potpore E-tracking na ultrazvučnom aparatu Alpha 10. Studentov t-test se koristio za 
statističku analizu te je alfa bila određena na <0,05. Sve ispitivane vrijednosti bile su lošije kod bolesnika s migrenom 
uključujući zadebljanu tuniku intime i medije, veći karotidni promjer i promjenu karotidnog promjera, kao i nekoliko in-
deksa arterijske krutosti. Uz to, bolesnici s migrenom imali su veću učestalost homozigotnih mutacija za prokoagulantne 
gene (MTHFR (C677T), PAI-1 and ACE I/D) nego što je očekivano. Kompjutorizirana tomografija i magnetska rezo-
nancija mozga zabilježile su oštećenje bijele moždane tvari kod 11 bolesnika, od kojih je 4 imalo migrenu s aurom. Kako 
smo zabilježili da postoji povećana arterijska krutost te veća učestalost mutacija prokoagulantnih gena kod bolesnika s 
migrenom, predlažemo da se takve osobe ultrazvučno prate, a osobito one kod kojih već postoji oštećenje bijele moždane 
tvari, kako bi se na vrijeme mogle poduzeti aktivne specifične mjere prevencije nastanka moždanih krvožilnih bolesti.
Ključne riječi: Migrenski poremećaji; Karotidna arterija, bolesti; Vaskularna krutost; Ateroskleroza; Moždani udar
